Validation of a Seizure Monitoring System
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Epilepsy
- Sponsor
- St Vincent's Hospital Melbourne
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Verify feasibility of using the LINQ device for epilepsy diagnosis, monitoring and management
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.
Investigators
Mark Cook
Principal Investigator
St Vincent's Hospital Melbourne
Eligibility Criteria
Inclusion Criteria
- •Patients with epilepsy
Exclusion Criteria
- •Women that are pregnant
- •Patients that are highly dependant on medical care
- •Patients that cannot give informed consent for themselves
Outcomes
Primary Outcomes
Verify feasibility of using the LINQ device for epilepsy diagnosis, monitoring and management
Time Frame: one week
Compare EEG from traditional scalp EEG to the LINQ recordings to determine if seizure activity can be accurately identified